Axonics Modulation Technologies (AXNX) Misses Q1 EPS by 16c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. WDC
3. DECK
4. BYD
5. WCN
6. SPOT
7. FIX
8. TSCO
9. BE
10. SLM

Go back to Axonics Modulation Technologies (AXNX) Misses Q1 EPS by 16c

Axonics® Reports First Quarter 2021 Financial Results

May 6, 2021 4:01 PM EDT

IRVINE, Calif.--(BUSINESS WIRE)-- Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today reported financial results for the first quarter ended March 31, 2021.

This quarters revenue result reflects growing demand for our long-lived r-SNM® system and Bulkamid® despite the resurgence of COVID cases in the U.S. in early 2021 and ongoing lockdowns in Europe, said Raymond W. Cohen, CEO of Axonics. Physician and patient satisfaction remains high and Axonics is poised to take full advantage of... More